Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2222 (LINC02222)

Target: LINC02222
Molecular classification: Long non-coding RNA, long intergenic non-coding RNA

Overview

LINC02222 (Long intergenic non-protein coding RNA 2222) is a human long intergenic non-coding RNA gene that produces a non-coding RNA transcript longer than 200 nucleotides and does not overlap any known protein-coding region[1][3]. lincRNAs as a class are involved in regulation of gene expression through mechanisms such as chromatin remodeling, RNA stabilization, transcription regulation, and post-transcriptional activity, but most lincRNAs, including LINC02222, remain poorly functionally characterized[3]. There is currently no evidence that LINC02222 acts as a therapeutic target, has disease associations, or interacts with drugs.

Other names: LINC02222

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2222 (LINC02222).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2222 (LINC02222).

Explore the full profile